Anastrozole With Fulvestrant Can Lengthen Lives Of Women With ER+ Metastatic Breast C

[News]

Post-menopausal women with hormone receptor-positive metastatic breast cancer may have a new treatment option that could lengthen their lives, according to results of a study by the SWOG clinical trials network that were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium...

More... (http://www.medicalnewstoday.com/releases/238822.php)